Skip to content

BioSig Technologies, Inc. STEX Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$46.69M+89.0%-$424.01M-2,621%-$15.58M+23.5%-$20.37M-627%-$2.8M-155%
$1.49M+1.6%$1.47M-1.3%$1.49M+169%$554K+2,538%$21K-30.0%
$25.37M-48.0%$48.82M+5,698%$842K-84.3%$5.37M+159%$2.07M
-$565K-15.5%-$489K
-$11K
$780K$761K-87.7%$6.19M+1,216%-$555K-110%
$0-100%$14K-65.9%$41K0.0%$41K0.0%
$1.93M$1.99M$70K+312%
$2.94M
-$3.06M-6,339%$49K0.0%$49K0.0%$49K0.0%$49K-92.2%
$0+100%-$15K+66.7%-$45K-7.1%-$42K+2.3%
$11.98M+3,392%$343K0.0%$343K0.0%$343K0.0%$343K
-$10.18M-237%-$3.02M+39.9%-$5.02M-293%-$1.28M-14.6%-$1.12M-135%
$10.19M
$25K
-$1.5M+93.9%-$24.47M
$11.34M0.0%$11.34M0.0%$11.34M0.0%$11.34M
$2.01M0.0%$2.01M0.0%$2.01M0.0%$2.01M
$37.18K$818K+81,700%
-$1.64M-104%$36.78M+175%$13.4M$0-100%$4.7M+469,900%
-$141K-729%-$17K
-$13.46M-245%$9.27M+12.7%$8.23M$0-100%$3.59M+858%
$403K
$25.37M-48.0%$48.82M+5,698%$842K-84.3%$5.37M+159%$2.07M
$11.98M+3,392%$343K0.0%$343K0.0%$343K0.0%$343K
-$1.75M0.0%-$1.75M0.0%-$1.75M0.0%-$1.75M
-$497K
$97.42M0.0%$97.42M0.0%$97.42M0.0%$97.42M
$2.01M0.0%$2.01M0.0%$2.01M0.0%$2.01M
-$199K
$3.25K0.0%$3.25K0.0%$3.25K0.0%$3.25K
-$17K+34.6%
$0+100%-$15K+66.7%-$45K-7.1%-$42K+2.3%
$1.93M$1.99M$70K+312%
-$9K+18.2%-$11K
-$119K
$6.12M0.0%$6.12M0.0%$6.12M0.0%$6.12M
$14.23M
$10.19M
$25K
$26.41M
$37.18M
$225K
$3.88M
$38.5M
$546K+1.9%$536K
$2.01M0.0%$2.01M0.0%$2.01M0.0%$2.01M
$170.75K0.0%$170.75K0.0%$170.75K0.0%$170.75K+460%
$189K
$15.76M
$2K$2K
$2.62M0.0%$2.62M0.0%$2.62M0.0%$2.62M
$3.75M0.0%$3.75M0.0%$3.75M0.0%$3.75M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does BioSig Technologies, Inc. generate?
BioSig Technologies, Inc. (STEX) generated -$19.5M in operating cash flow over the trailing twelve months.
Where does BioSig Technologies, Inc.'s cash flow data come from?
Every line is extracted from BioSig Technologies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.